Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2005
10/27/2005WO2005100406A1 Function proteins of high potency and low toxicity
10/27/2005WO2005100403A2 Antibodies to erythropoietin receptor and uses thereof
10/27/2005WO2005100395A2 EXPRESSION SYSTEM FOR PREPARING IL-15/Fc FUSION PROTEINS AND ITS USE
10/27/2005WO2005100388A1 Production of insulinotropic peptides
10/27/2005WO2005100383A2 Novel hiv+ infected cells targeting retroviral vectors and uses thereof for treatment of hiv infection
10/27/2005WO2005099889A1 Process for producing hollow nanoparticle with use of liposome as template
10/27/2005WO2005099771A2 Methods and compositions for treating neuropathic and neurodegenerative conditions
10/27/2005WO2005099770A2 Pancreatic islet microrna and methods for inhibiting same
10/27/2005WO2005099741A1 Remedy for motoneuron diseases
10/27/2005WO2005099449A2 Animal model, cells, and treatment for malignant melanoma
10/27/2005WO2005099441A1 Method of screening agrichemical capable of inducing disease resistance and plant for use in the method
10/27/2005WO2005099440A2 Methods for recovering products from plants
10/27/2005WO2005099335A2 Methods for predicting the risk of diabetic nephropathy using genetic markers and arrays containing the same
10/27/2005WO2005083119A3 Hybridization method as well as hybridization microarray and hybridization kit
10/27/2005WO2005078097A3 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING MULTIFUNCTIONAL SHORT INTERFERING NUCLEIC ACID (Multifunctional siNA)
10/27/2005WO2005073371A3 Enhanced secretion/retention of growth hormone releasing hormone (ghrh) from muscle cells by species-specific signal peptide
10/27/2005WO2005068629A3 Gene expression inhibition and uses thereof
10/27/2005WO2005068617A3 Fungal beta-glucuronidase genes and gene products
10/27/2005WO2005068616A3 Immunokinases
10/27/2005WO2005066349A3 Genes encoding proteins with pesticidal activity
10/27/2005WO2005065707B1 Recombinant vaccine against japanese encephalitis virus [jev] infection and a method thereof
10/27/2005WO2005065348A3 Transactivation system for mammalian cells
10/27/2005WO2005055703A3 Method of modifying plant phenotypes with nonsymbiotic hemoglobin
10/27/2005WO2005049845A3 Oncolytic herpes simplex virus encoding a heterologous nitroreductase
10/27/2005WO2005048693A3 Plant with improved drought tolerance
10/27/2005WO2005037854A3 Immunogenic peptides
10/27/2005WO2005033311A3 Methods for modulating neuronal responses using inhibitors of ampa receptor endocytosis
10/27/2005WO2005030968A3 Actin regulatory elements for use in plants
10/27/2005WO2005027625A3 Transgenic tieg non-human animals
10/27/2005WO2005012531A3 Antibody cdr polypeptide sequences with restricted diversity
10/27/2005WO2005007871B1 Genetic marker of response to atypical antipsychotics and antidepressants and methods for use thereof
10/27/2005WO2005007853A3 Inhibition of apoptosis-specific elf-5a (“eif-5a1”) with antisense oligonucleotides and sirnas as anti-inflammatory therapeutics
10/27/2005WO2005007826A3 Production of aromatic carotenoids in gram negative bacteria
10/27/2005WO2005007825A3 Modulation of aminopeptidase n expression
10/27/2005WO2005007699A8 Human antibody molecules for il-13
10/27/2005WO2004094598A3 Methods of use for novel human polypeptides encoded by polynucleotides
10/27/2005WO2004081030A8 Peptides selectively lethal to malignant and transformed mammalian cells
10/27/2005WO2004078940A8 USE OF ANTISENSE OLIGONUCLEOTIDES OR siRNA TO SUPPRESS EXPRESSION OF eIF-5A1
10/27/2005WO2004076629A3 METHODS AND CONSTRUCTS FOR EVALUATION OF RNAi TARGETS AND EFFECTOR MOLECULES
10/27/2005WO2004072284A8 Modulation of insulin like growth factor i receptor expression
10/27/2005WO2004065558A3 Depletion of endogenous primordial germ cells in avian species
10/27/2005WO2004064760A3 Aptamer therapeutics useful in ocular pharmacotherapy
10/27/2005WO2004033707A3 Extraction of dna from biological samples
10/27/2005WO2003064600A3 The il-1 gene cluster and associated inflammatory polymorphisms and haplotypes
10/27/2005WO2003054163A3 Methods for producing hyaluronan in a recombinant host cell
10/27/2005WO2003029277A3 Modulators of lymphocyte activation and migration
10/27/2005WO2003023008A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/27/2005US20050241025 Soybean containing high levels of free amino acids
10/27/2005US20050241024 Transgenic plant-based vaccines
10/27/2005US20050241023 Transgenic plants expressing assembled secretory antibodies
10/27/2005US20050241022 Transgenic Brasica; expression cassettes; ribuolse bisphosphate carboxylase (Rubisco)
10/27/2005US20050241021 Acetolactate synthase gene promoter
10/27/2005US20050241020 Transgenic corn having enhanced nutritional qualities
10/27/2005US20050241018 Arcelin-5 promoter and uses thereof
10/27/2005US20050241017 Manipulation of genes of the mevalonate and isoprenoid pathways to create novel traits in transgenic organisms
10/27/2005US20050241016 Plant centromere compositions
10/27/2005US20050241015 Glycine max plant cell with minichromosome that is not integrated into genome and comprises centromere sequence which confers ability to segregate to daughter cells and at least 5 repeated nucleotide sequences; genetic engineering
10/27/2005US20050241014 Nutritionally enhanced plants
10/27/2005US20050241011 Enclosed aquacultural systems for production of purified recombinant proteins
10/27/2005US20050241009 Development of a murine model of HIV-1 infection on the basis of construction of EcoHIV, a chimeric, molecular clone of human immunodeficiency virus type 1 and ecotropic moloney murine leukemia virus competent to infect murine cells and mice
10/27/2005US20050241008 Transgenic models of Alzheimer's disease and uses therefor in the treatment of a variety of neurodegenerative diseases
10/27/2005US20050241007 Frog prince, a transposon vector for gene transfer in vertebrates
10/27/2005US20050240014 Connective tissue growth factor homologs
10/27/2005US20050240010 Nucleic acids encoding antagonists of interleukin-15
10/27/2005US20050240009 T-cell epitopes in staphylococcal enterotoxin b
10/27/2005US20050240008 Novel protein, dna thereof and process for producing the same
10/27/2005US20050240006 Cytoplasmic region with more than 107 or less than 104 amino acids, a transmembrance region, and an extracellular region; nucleic acids and antibodies; diagnosing hematopoietic cell malignancy or autoimmune disease
10/27/2005US20050239738 Genetic inhibition of epidermal growth factor receptor function and carcinoma cell radiosensitization
10/27/2005US20050239737 Identification of molecular interaction sites in RNA for novel drug discovery
10/27/2005US20050239734 C-class oligonucleotide analogs with enhanced immunostimulatory potency
10/27/2005US20050239733 Sequence requirements for inhibitory oligonucleotides
10/27/2005US20050239732 Immunostimulatory nucleic acid molecules
10/27/2005US20050239731 chemically synthesized double stranded siNA against p38 RNA; use against diseases such as cancer, inflammatory, autoimmune, and/or proliferative disorders
10/27/2005US20050239730 Plasmodium falciparum erythrocyte binding protein baebl for use as a vaccine
10/27/2005US20050239728 Double stranded rna structures and constructs, and methods for generating and using the same
10/27/2005US20050239708 Use of factor VIIa or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
10/27/2005US20050239702 Methods of modulating FabH activity
10/27/2005US20050239699 Remedy for infections
10/27/2005US20050239696 Gmg-3 gmg-4 and gmg-6 polynucleotides and polypeptides and uses thereof
10/27/2005US20050239205 Gb virus b based replicons and replicon enhanced cells
10/27/2005US20050239204 Multifunctional molecular complexes for gene transfer to cells
10/27/2005US20050239203 Regulation of endogenous gene expression in cells using zinc finger proteins
10/27/2005US20050239202 Methods and compositions for inhibiting the function of polynucleotide sequences
10/27/2005US20050239201 Methods of inducing differentiation of stem cells into a specific cell lineage
10/27/2005US20050239188 Virus envelope vector for gene transfer
10/27/2005US20050239187 Methods to culture circovirus
10/27/2005US20050239186 Peptidyl-tRNA hydrolase of Enterococcus faecalis
10/27/2005US20050239185 Protease variants and compositions
10/27/2005US20050239180 Nucleotide sequence coding for a mannitol-2 dehydrogenase and method for the production of d-mannitol
10/27/2005US20050239179 Producing 3-hydroxypropionic acid from transgenic organisms such as plants or bacteria that express vicinal diol dehydratase, aldehyde dehydrogenase, acyl-CoA transferase, acyl-CoA synthetase, polyhydroxyalkanoate synthase, glycerol-3-phosphate dehydrogenase and/or glycerol-3-phosphatase
10/27/2005US20050239177 Novel gene and method for producing L-amino acids
10/27/2005US20050239176 Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria
10/27/2005US20050239175 Method for producing L-amino acid using bacteria belonging to the genus Escherichia
10/27/2005US20050239172 Methods and DNA constructs for high yield production of polypeptides
10/27/2005US20050239170 Alpha-MSH related compounds and methods of use
10/27/2005US20050239169 Nucleotide sequences coding seladin-1polypeptide for use in treatment and prevention of alzheimer's disease
10/27/2005US20050239168 Detecting moderators of kinase peptide; encoding genes
10/27/2005US20050239167 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
10/27/2005US20050239166 Polynucleotides encoding human secreted protein, ZZP1
10/27/2005US20050239164 Glutathione production
1 ... 1922 1923 1924 1925 1926 1927 1928 1929 1930 1931 1932 1933 1934 1935 1936 1937 1938 1939 1940 1941 1942 ... 4023